Dileep Atluri is a Gastroenterology physician. OpenAlex indexes 17 publications with 233 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11795 Education St Ste 213
Auburn, CA 956022469
Telephone
530-886-6800Registry record last updated 12 Feb 2019.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20253 payments
- Ipsen Biopharmaceuticals, IncProgram year20251 payment
- Organon LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
87.6%Proton pump inhibitor50.5%Pantoprazole Sodium81%Omeprazole19%Part D≥49 patientsAminosalicylate14.5%Mesalamine100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
8.1%Aldosterone antagonist (MRA)4.2%Spironolactone100%Part D<11 patientsBile Acid Sequestrant3.9%Cholestyramine100%Part D<11 patientsAnti-infectives
4.2%Nitroimidazole Antimicrobial4.2%Metronidazole100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Systematic review with meta‐analysis: selective serotonin reuptake inhibitors for noncardiac chest pain
Alimentary Pharmacology & Therapeutics
2014 - Effect of linaclotide in irritable bowel syndrome with constipation (<scp>IBS</scp>‐C): a systematic review and meta‐analysis
Neurogastroenterology & Motility
2013 - Effect of Linaclotide in Improving Quality of Life in Patients with Constipation-predominant Irritable Bowel Syndrome (IBS-C)
The American Journal of Gastroenterology
2013 - Effect of Linaclotide in Treatment of Constipation-predominant Irritable Bowel Syndrome (IBS-C): A Systematic Review and Meta-analysis
The American Journal of Gastroenterology
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”